Melanoma Research Review, Issue 13

In this issue:

Ipilimumab adjuvant therapy for stage III melanoma
Sunscreen use and melanoma risk
A gene expression signature to differentiate malignant melanoma from benign nevi
Prevalence of perianal melanocytic nevi
Metabolic activity in patients with melanoma treated with pazopanib and paclitaxel
Sensitivity and specificity of MDSLA vs RCM in the detection of melanoma in vivo
Practice patterns of US dermatologists for management of patients with primary cutaneous melanoma
MAL and vitiligo cannot be differentiated based on blinded assessment by experts
Nivolumab + ipilimumab vs ipilimumab alone in patients with advanced melanoma
Impact of postoperative lymph node radiation therapy on OS of patients with stage III melanoma

Please login below to download this issue (PDF)

Subscribe